Navigation Links
MO BIO Laboratories, Inc. Becomes Exclusive Sponsor Of Nature's Human Microbiota Special
Date:8/21/2012

CARLSBAD, Calif., Aug. 21, 2012 /PRNewswire/ -- MO BIO Laboratories, Inc., the leader in microbial nucleic acid purification, is pleased to announce their sponsorship of Nature's Special: Human Microbiota, enabling free access to four of Nature's recent human microbiome publications.

"MO BIO is committed to furthering human microbiome research through the development of nucleic acid isolation kits optimized for difficult samples, including stool and gut material," Mark Brolaski, President and CEO of MO BIO Laboratories, said. "We are proud to have the opportunity to make these important human microbiome publications freely available to the scientific community."

Free access to four recent human microbiome publications is available now. For more information, visit the MO BIO website (www.mobio.com/microbiome).

MO BIO Laboratories, Inc. (www.mobio.com) has developed innovative tools for researchers in molecular biology since 1993. MO BIO's PowerSoil DNA and PowerMicrobiome™ RNA Isolation Kits are designed for fast and easy purification of nucleic acids from samples high in PCR inhibitors; including stool and gut material. Patented Inhibitor Removal Technology® ensures complete removal of inhibitory substances from digested food, heme from lysed red blood cells, and other PCR inhibitors. Nucleic acids are ready to use in the most demanding downstream applications, including qPCR and next generation sequencing. MO BIO's new PowerMag™ Soil DNA Isolation Kit is also available for high-throughput, hands-free isolation of DNA from stool and gut samples. It is MO BIO's aim to make researchers' working lives more productive and efficient, creating time to focus on what is critical, not just in work, but in life.


'/>"/>
SOURCE MO BIO Laboratories, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Frost & Sullivan Presents 2012 Clinical Diagnostics Company of the Year Award to GenPath Diagnostics of BioReference Laboratories, Inc.
2. MO BIO Laboratories, Inc. Launches the PowerMicrobiome™ RNA Isolation Kit
3. Good Shepherd Rehabilitation Network Becomes Third Health-Care Organization in U.S. to Have Ekso Exoskeleton
4. Adeona Becomes Synthetic Biologics, Inc.
5. Synthetic Biologics and Intrexon Corporation Enter Worldwide Exclusive Collaboration for Infectious Diseases
6. JG Finneran Associates Appoints Chebios as its Exclusive Distributor in Italy
7. UK supplier of graphenes announces exclusive sales agency agreement with leading USA distributor
8. Hamamatsu Corporation Announces Exclusive Distribution of Its NanoZoomer Whole-Slide Scanners
9. PTV Interview Exclusive: Revolutionary GSK and J&J Participation in New Index Ventures Fund
10. Marken Launches Exclusive Shipping System for Specimen Logistics
11. Heptares Grants Shire an Exclusive Worldwide Licence to Develop and Commercialise Novel Drug Candidate for CNS Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... ... August 18, 2017 , ... ... will feature Federal Hybrids, Inc. in an upcoming episode, scheduled to broadcast fourth ... Farmer will explore Federal Hybrids, the independent, family-owned seed company. Educating audiences about ...
(Date:8/17/2017)... , ... August 17, 2017 , ... ... stock market news outlet had provided a research update on Aytu Bioscience and ... TRT product. , According to Soulstring, prescription rates for Natesto® have more than ...
(Date:8/16/2017)... King of Prussia, PA (PRWEB) , ... August 16, 2017 , ... ... leaders will be taking part in sessions at the ISPE Annual Meeting and ... the Marriott Marquis San Diego Marina. The event’s theme is “Driving innovation to advance ...
(Date:8/16/2017)... ... August 16, 2017 , ... ... a different cell type. Many treatments for specific cancers, such as breast, prostate, ... targeted treatment is androgen deprivation therapy for advanced prostate cancer. , This ...
Breaking Biology Technology:
(Date:3/30/2017)... 30, 2017 Trends, opportunities and forecast in ... by technology (fingerprint, AFIS, iris recognition, facial recognition, hand ... by end use industry (government and law enforcement, commercial ... banking, and others), and by region ( North ... Asia Pacific , and the Rest of ...
(Date:3/27/2017)... 27, 2017  Catholic Health Services (CHS) has ... Society (HIMSS) Analytics for achieving Stage 6 on ... . In addition, CHS previously earned a place ... an electronic medical record (EMR). "HIMSS ... of EMR usage in an outpatient setting.  This ...
(Date:3/23/2017)... report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based and Touchless), Product ... by MarketsandMarkets, the market is expected to be worth USD 18.98 billion by ... Continue Reading ... ...      (Logo: http://photos.prnewswire.com/prnh/20160303/792302) ...
Breaking Biology News(10 mins):